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Methods: Opticin was extracted from normal and OA human cartilage
using guanidinium chloride (4M) extraction and examined by Western
blotting. Human MMP 1, -2, -3, -7, -8, -9 and ADAMTS-4, -5 proteolytic
activities on opticin were analyzed on normal and OA cartilage extracts
incubated for 0−24 hours
Results: One of the emerging observations was that all MMPs and
ADAMTS tested, except MMP-9, cleaved opticin in both normal and OA
specimens. Interestingly, MMP-7 and -8 were the most effective, and
degradation occurred as early as 15 minutes of incubation. At which
time, degradation was almost complete for MMP-7, suggesting that this
molecule is a preferential substrate for this enzyme. In contrast, MMP-1
was the least effective and degradation was noted after an incubation
of 16 hours. The others enzymes showed degradation starting at about
2 hours. The degradation pattern, except for MMP-7 in which degradation
appeared independent of the specimen types, was different between
normal and OA. In general, the degradation pattern was slower in normal
than in OA specimens, reﬂecting an increased sensitivity of opticin to
degradation when the cartilage was damaged. Fragments were also
detected, but the number and size differed depending on the protease.
This indicates different digestion sites among the proteases. Surprisingly,
MMP-1 and -2 generated different opticin degradation fragments when
normal were compared to OA specimens. The different opticin protease
cleavage sites are currently under study.
Conclusions: We showed, for the ﬁrst time, the ability of different MMP
and ADAMTS to degrade opticin. As opticin may contribute to the struc-
tural stability of cartilage matrix, its cleavage may predispose cartilage to
degradation. In vivo identiﬁcation of the cleavage products may assist in
an early detection of OA cartilage matrix degeneration.
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Purpose: Diabetes mellitus is an important risk factor for osteoarthritis
(OA), but the mechanisms involved are largely unknown. In chondrocytes,
glucose is essential for energy production and the synthesis of matrix
components. Diabetic patients can experience extended episodes of
hyper- and hypoglycemia that are likely to affect the delivery of glucose
to the synovial joint and its availability to chondrocytes. Glucose transport
is the limiting step in glucose utilization and the facilitative glucose
transporter-1 (GLUT-1) is the major glucose transporter in chondrocytes.
This study aimed at comparing the ability of normal and OA chondrocytes
to regulate glucose uptake and GLUT-1 levels in response to high and
low extracellular glucose concentrations.
Methods: Normal human chondrocytes were isolated from the femoral
condyles of multi-organ donors. OA chondrocytes were isolated from
the cartilage obtained from patients undergoing total knee replacement
surgery. Serum-starved subconﬂuent chondrocyte cultures were incu-
bated in media with 0, 10 or 30mM glucose. Total GLUT-1 content
was evaluated by western blotting. Glucose transport was determined
by measuring the uptake of non-metabolizable 2-Deoxy-D-2-[2,6-3H] glu-
cose into chondrocytes for 30 minutes at 37ºC. GLUT-1 gene expression
was measured by Real Time PCR. To determine the role of lysosomes in
GLUT-1 regulation, chondrocyte cultures in regular (10mM glucose) or
high glucose (30mM) medium were treated with 20 mM chloroquine, an
inhibitor of lysosome function, for the last 6 hours of an 18 hour incubation
period.
Results: Treatment of normal chondrocytes with 30mM glucose for
either 18 or 48 hours signiﬁcantly decreased 2-Deoxy-D-Glucose uptake
(75.4±3.6% and 71.5±2.6%, respectively) and GLUT-1 protein levels
(68.2±9.1% and 64.6±6.0%, respectively) relative to cells cultured under
10mM glucose. In contrast, 2-Deoxy-D-Glucose uptake (102.5±3.1%)
and GLUT-1 levels (116.51±9.6%) remained unchanged in OA chon-
drocytes cultured for 48 hours in the high glucose medium. GLUT-1
mRNA levels, either in normal or OA chondrocytes, were not affected by
treatment with high glucose for 6, 12 or 24 h. Similarly to normal cells, OA
chondrocytes responded to glucose deprivation by increasing 2-Deoxy-
D-Glucose uptake (128±2%) and total GLUT-1 levels (137.8±8.6%).
Treatment with 20mM chloroquine signiﬁcantly increased total GLUT-1
protein in normal chondrocytes, both under regular (10mM) and high
glucose conditions.
Conclusions: OA chondrocytes are capable of upregulating the net rate
of glucose transport and GLUT-1 protein when deprived of glucose,
suggesting that they are capable of sensing and adjusting to low extracel-
lular glucose concentrations. However, unlike normal chondrocytes, OA
chondrocytes fail to downregulate glucose transport and GLUT-1 protein
under high glucose concentrations. This may lead to an abnormally high
intracellular glucose concentration, which in turn may lead to altered cell
function and the formation of glycation end products during extended
periods of hyperglycemia in vivo. The lack of signiﬁcant differences in
GLUT-1 mRNA, together with GLUT-1 accumulation in normal chon-
drocytes exposed to chloroquine, indicate that GLUT-1 downregulation
depends on lysosomal degradation. The role of lysosomal function in
the inability of OA chondrocytes to adequately respond to high glucose
remains to be elucidated.
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Purpose: Previously we have shown that cartilage chondrocyte alkaline
phosphatase (ALP) is up regulated in active osteoarthritis (OA) and down
regulated in calcium pyrophosphate dihydrate (CPPD) crystal deposition
disease. Furthermore, CPPD crystals can be dissolved by the action
of ALP provided that the enzyme is bound to the crystals. Modulating
the action of ALP would then suggest a possible route to affect these
conditions. To obtain a better understanding of the action of ALP on
CPPD crystal dissolution, we investigated inhibition by endogenous amino
acids on ALP substrates; organic phosphate, inorganic pyrophosphate,
and CPPD crystals.
Methods: CPPD crystals were made using established methods de-
veloped in our laboratory. The phosphatase (Piase), pyrophosphate
hydrolase (PPiase), and CPPD crystal dissolution activities of tissue
nonspeciﬁc alkaline phosphatase (TNAP) were investigated in vitro using
cysteine and mercaptopyruvate (MPA) as inhibitors of Bovine kidney
ALP. Enzyme activity was determined by measuring liberated inorganic
phosphate (Pi) from p-Nitrophenyl phosphate (pNPP), or Sodium py-
rophosphate, at speciﬁc times and conditions. CPPD crystal dissolution
was assessed by measuring [Pi] liberated into solution in the presence of
TNAP. To assess enzyme inhibition, kinetics parameters such as Vmax
and Km, were determined and speciﬁc activities were calculated from Ini-
tial Velocity, Eadie-Hofstee, Simple, Dixon, and Secondary plots. Assays
were run under physiologic conditions with Tris-HCl buffer, pH=7.4 and at
37ºC. TNAP was at 200U/L and the buffer was supplemented with 1mM
Ca++ and 1mM Mg++. Enzyme activity was expressed as nmoles Pi/unit
TNAP/minute.
Results: At physiologic concentration, cysteine had no inhibitory effect
on any activity of TNAP. At 10× physiologic concentration, cysteine
signiﬁcantly inhibited phosphatase and pyrophosphate hydrolase activity
but did not inhibit CPPD crystal dissolution. MPA and cysteine together
inhibited TNAP’s phosphatase and pyrophosphate hydrolase activity at
physiologic concentration while CPPD crystal dissolution was only slightly
inhibited. When the two inhibitors were increased to 10x physiologic
concentration, all enzyme activity decreased signiﬁcantly as is shown
in the summary table.
Effect of Amino Acid Inhibitors on Enzyme Activity
Enzyme Substrate Inhibitors
Concentration nmolesPi/unit ALP/Minute
× physiological Cysteine Cysteine + MPA
% %
ALP (Piase) pNPP 2000uM 0 29 100 28 100
1× 28 98 8 29
10× 11 37 4 14
ALP (PPiase) Pyrophosphate 2000 uM 0 27 100 55 100
1× 30 110 21 39
10× 18 66 19 34
ALP CPPD 50ug/mL 0 0.46 100 0.26 100
1× 0.49 107 0.23 88
10× 0.43 93 0.10 38
Conclusions: The amino acids cysteine and MPA together are capable of
inhibiting phosphatase and pyrophosphate hydrolase activity of TNAP at
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concentrations approximating their physiologic concentration in cartilage.
As well, there is a differential inhibition of organic phosphatase, pyrophos-
phate hydrolase, and CPPD crystal dissolution activity by these amino
acids. In OA, there is a potential for bone ALP to be down regulated by
increasing the concentration of inhibiting amino acids or their analogues.
In CPPD, sequestration of inhibitory amino acids may permit sufﬁcient
ALP activity to facilitate CPPD crystal dissolution.
204 ESE-1 REGULATES BASAL EXPRESSION OF MMP-13 IN
CHONDROCYTES
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Special Surgery, New York, NY, USA
Purpose: Among the matrix metalloproteinases (MMPs), MMP-13 plays
a major role in osteoarthritis (OA) due to its-rate limiting role in the
collagen degradation. MMP-13 expression is regulated by a variety of
transcription factors, including members of the ETS family such as ETS-2
and Elk-1, but the precise transcriptional mechanism is not completely
understood. ESE-1 is expressed in non-epithelial tissues after treatment
with inﬂammatory cytokines and we reported recently that ESE-1 re-
presses the type II collagen gene (COL2A1) in human chondrocytes.
These observations suggest a fundamental role of ESE-1 in cartilage
degeneration and suppression of repair. The aim of this study was to
determine whether ESE-1 participates in the MMP-13 transcriptional
regulation in chondrocytes.
Methods: The binding of in vitro-translated ESE-1 to the MMP-13 pro-
moter was analyzed by electrophoretic mobility shift assay (EMSA) and
supershift analysis. For knockdown of ESE-1 expression, the human
chondrocytic C-28/I2 cells were transfected with a pool of four individual
siRNA oligonucleotides against ESE-1 or control nonspeciﬁc siRNA. After
incubation for 72 hours, the knockdown was conﬁrmed by real time PCR
and Western blotting, and MMP-13 mRNA was analyzed by real time
PCR. MMP-13 protein in Ese1 (Elf3)-deﬁcient mice was addressed by
immunohistochemical staining.
Results: Three highly conserved ETS binding sites were revealed in
the proximal region of the MMP-13 promoter. By EMSA and supershift
analysis, we detected speciﬁc binding of ESE-1 to all three sites in the
proximal MMP-13 promoter, with stronger binding to the site containing
2 tandem ETS sites. These results suggested that ESE-1 could be
regulating the MMP-13 promoter activity. By using speciﬁc siRNA oligos,
we knocked down the ESE-1 expression in C28/I2 cells. Real time PCR
analysis revealed lower MMP-13 basal expression associated with ESE-1
knockdown. This result suggests that ESE-1 is necessary for maintaining
the MMP-13 basal expression levels. Finally, the immunohistochemical
analysis of the Elf3-deﬁcient mouse cartilage revealed low or unde-
tectable MMP-13 protein levels in comparison with age-matched wild type
cartilage samples, although type II collagen staining was similar with no
evidence of proteoglycan loss.
Conclusions: Our previous results highlighted ESE-1 as an important
transcriptional regulator of cartilage degenerative processes. After induc-
tion, ESE-1 transactivates both NOS2 and COX2 promoters by interacting
with NFúB. In addition, we showed recently that ESE-1 represses the
COL2A1 in human chondrocytes and that ESE-1 immunostaining is high
in human OA cartilage, whereas it is not present or undetectable in
control cartilage. In this work we show that ESE-1 binds directly to the
MMP-13 proximal promoter region and that knocking down the ESE-1
expression leads to decreased MMP-13 basal expression levels. These
results suggest that, among others, ESE-1 is a key factor for maintaining
the MMP-13 basal expression. Moreover, our ﬁnding that MMP-13 protein
levels are decreased or absent in the cartilage of Elf3-deﬁcient mice
further reinforces the role of the ESE-1 in maintaining MMP-13 basal
expression. However, the lack of evidence of collagen degradation in
wild type samples indicates that activation of the proenzyme requires
additional stimuli. Altogether, our results suggest a fundamental role for
ESE-1 in controlling MMP-13 gene expression in chondrocytes. Further
work will be required to determine its role in progressive cartilage loss
during OA.
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MINERAL STRUCTURE IN OSTEOARTHRITIS
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Purpose: Increased subchondral bone thickness, altered bone mineral
density distribution, and trabecular microfractures are characteristic mor-
phologic features of osteoarthritis. However on the microscopic scale,
(mm), the bone mineralization patterns remain to be elucidated. To
develop a better understanding of subchondral bone mineralization in
osteoarthritis and to explore the utility of high voltage, high resolution
x-ray microscopy in resolving bone structure, we studied the articular
bone plate and subchondral bone trabeculae in ten cases of osteoarthritis
using CPPD crystal deposition disease and osteoporosis cases as control
tissues.
Methods: Five mm coronal blocks were taken from the femoral condyles
at cross sections where osteoarthritis was maximal and where articular
cartilage was still present. These blocks were adjacent to blocks taken
for routine diagnostic analysis. The formalin-ﬁxed blocks were studied
using a Comet Feinfocus 160.25 x-ray microscopy system (focal spot
<1mm). For this study, magniﬁcation was set at the highest practical level
to obtain clear images, projection magniﬁcation = 28×. X-ray exposures
were optimized to characterize the bone mineral structure (80 kV, 45 uA).
Magniﬁcation was calibrated using a copper electron microscope grid
diameter = 3mm, with grid line width = 35 mm.
Results: Samples clearly showed resolution of features less than 10 mm
in width and demonstrated different mineralization density within bone
structures. Figure 1 shows a sample range of the initial morphologic
observations. The osteoporosis control, Fig. 1.3 shows subchondral bone
with similar density to that of the bone trabeculae (bars) as well as ex-
tensive but focal, trabecular microfractures with increased mineralization
(arrow). Samples from osteoarthritis patients, Fig. 1.2 and 1.3, demon-
strated increased bone mineral density within the subchondral plate.
However, Fig. 1.3 showed extensive trabecular microfractures with highly
mineralized density compared to normal trabeculae whereas Fig. 1.2
did not. In Fig. 1.4 from the calcium pyrophosphate crystal deposition
disease, the image shows a morphologic pattern more closely resembling
osteoporosis Fig. 1.3 than osteoarthritis.
Conclusions: These studies show that X-ray microscopy is a promising
tool to delineate subsets of subchondral bone response in osteoarthritis.
The observations conﬁrm that subchondral osteosclerosis in osteoarthritis
is related to increased bone mineral density of the subchondral bone plate
irrespective of bone thickness. However, trabecular microfractures with
increased mineralization density occurs only in a portion of patients with
osteoarthritis. This indicates that the subchondral bone trabecular struc-
ture and mineralization distribution in osteoarthritis is heterogeneous.
Most likely, this reﬂects different types of osteoarthritis with differential
bone mineralization response, rather than different stages of the disease.
Figure 1.
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OSTEOATHRITIC KNEES INCREASES
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Purpose: Research in osteoarthritis (OA) has in recent years suggested a
relationship between chondrocyte telomere length and severity of OA. We
